Timetable: Post-authorisation safety study (PASS) protocols and final results
Submitted by Anonymous (not verified) on 8 May 2024 - 14:29
Timetable: Post-authorisation safety study (PASS) protocols and final results
Timetable: Initial (Full) marketing authorisation application - ATMP
Submitted by Anonymous (not verified) on 8 May 2024 - 9:22
Timetable: Initial (Full) marketing authorisation application - ATMP
Organisation chart: Advisory functions
Submitted by Anonymous (not verified) on 7 May 2024 - 15:39
Organisation chart: Advisory functions
Need for maximum residue limit (MRL) evaluation for biological substances - Scientific guideline
Submitted by Anonymous (not verified) on 7 May 2024 - 15:00
Need for maximum residue limit (MRL) evaluation for biological substances - Scientific guideline
Herbal medicinal product: Hippocastani cortexArray, F: Assessment finalised
Submitted by Anonymous (not verified) on 7 May 2024 - 13:51
Herbal medicinal product: Hippocastani cortexArray, F: Assessment finalised
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024
Submitted by Anonymous (not verified) on 7 May 2024 - 13:17
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024
EMA closed 9-10 May
Submitted by Anonymous (not verified) on 7 May 2024 - 13:00
EMA closed 9-10 May
Information session on Call for Proposals "EU 4 AMA: leveraging European expertise for medicines regulation in Africa", Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2024, 10:00 (CEST) to 22 May 2024, 11:00 (CEST)
Submitted by Anonymous (not verified) on 7 May 2024 - 12:37
Information session on Call for Proposals "EU 4 AMA: leveraging European expertise for medicines regulation in Africa", Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2024, 10:00 (CEST) to 22 May 2024, 11:00 (CEST)
List of medicines currently in PRIME scheme
Submitted by Anonymous (not verified) on 7 May 2024 - 12:21
List of medicines currently in PRIME scheme
One Health: a joint framework for action published by five EU agencies
Submitted by Anonymous (not verified) on 7 May 2024 - 11:00
One Health: a joint framework for action published by five EU agencies